GGrantIndex
← Leaderboards

Van Andel Research Institute

Grand Rapids, MI

Compare ↔
$242,075,257
Total funding
185
Grants

Funding over time

peak $31.3M · FY2005–25
$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$231,508,906 · 167
DOD$6,789,861 · 11
NSF$2,556,489 · 6
DOE$1,220,001 · 1

By mechanism

R01$144,691,727 · 80
R35$29,143,299 · 11
U01$13,577,407 · 5
R21$11,227,783 · 23
—$10,566,351 · 18
N02$7,912,119 · 1

Investigators at Van Andel Research Institute

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Russell Jones$4,409,1813 gr2Sara Marie Nowinski$3,191,7753 gr3Evan J Worden$2,422,5002 gr4Timothy J. Triche$809,4692 gr5Travis Walton$528,0001 gr6Zheng Ruan$490,5281 gr7Hyo Sik Jang$249,0001 gr8Nagy A. Youssef$229,8631 gr

Emerging Leaders

6–10 yrs in

1Wei Lu$8,211,4234 gr2John Andrew Pospisilik$7,448,8895 gr3Juan Du$5,679,7823 gr4Tao Yang$4,067,7793 gr5Hui Shen$3,373,0851 gr6Rita Guerreiro$3,124,6971 gr7Hong-Yuan Chu$3,066,1173 gr8Hong Wen$3,004,5752 gr

All-Time

Most funded here, all years

1Peter W Laird$24,354,34214 gr2Peter A Jones$23,463,9086 gr3Gerd P Pfeifer$23,178,44713 gr4Darren John Moore$10,901,16710 gr5Sara A Courtneidge$10,653,8158 gr6H Eric Xu$10,075,8135 gr7Wei Lu$8,211,4234 gr8John Andrew Pospisilik$7,448,8895 gr

Largest grants

Biospecimen Core Resource (BCR) services$7,912,119
N02 · FY2022 · CA
Master regulators of unexplained variation in disease risk$1,928,798
R01 · FY2024 · HG
Master regulators of unexplained variation in disease risk$1,928,796
R01 · FY2025 · HG
Master regulators of unexplained variation in disease risk$1,922,580
R01 · FY2023 · HG
Master regulators of unexplained variation in disease risk$1,919,218
R01 · FY2022 · HG
Master regulators of unexplained variation in disease risk$1,913,232
R01 · FY2021 · HG
IDENTIFYING MICROBIAL MECHANISMS THAT REGULATE ANIMAL INSULIN SIGNALING$1,710,000
DP2 · FY2023 · DK
Mitochondrial Oxidative Metabolism is a critical determinant of Muscle Satellite Cell fate & function$1,622,775
R01 · FY2025 · AR
Ketone Body Metabolism in CD8+ T Cell Responses$1,301,502
R01 · FY2025 · AI
STRUCTURAL MECHANISM OF ENERGY CONSERVATION IN HYPERTHERMOPHILES$1,220,001
· FY2019 · Department of Energy
DEFINING THE EFFECTS OF A-SYNUCLEIN PATHOLOGY ON THE AMYGDALA CIRCUITRY: RELEVANCE TO NEUROPSYCHIATRIC DYSFUNCTION IN PARKINSON'S DISEASE$1,200,000
· FY2021 · Defense Health Agency
Establishing and Interpreting Abnormal DNA Methylation in Cancer$1,146,514
R35 · FY2023 · CA
Targeting DNA Methylation and the Cancer Epigenome$1,139,837
R35 · FY2017 · CA
AIRBORNE POLLUTANTS AS TRIGGERS OF PARKINSONS DISEASE VIA THE OLFACTORY SYSTEM$1,131,925
· FY2017 · Department of the Army
Targeting DNA Methylation and the Cancer Epigenome$1,117,337
R35 · FY2018 · CA
Targeting DNA Methylation and the Cancer Epigenome$1,117,337
R35 · FY2020 · CA
Targeting DNA Methylation and the Cancer Epigenome$1,117,337
R35 · FY2021 · CA
MECHANISMS OF DEVELOPMENTAL PLASTICITY$1,100,000
· FY2024 · BIO
Targeting DNA Methylation and the Cancer Epigenome$1,094,991
R35 · FY2022 · CA
Targeting DNA Methylation and the Cancer Epigenome$1,094,991
R35 · FY2023 · CA